Skip to main content

Tekla Capital Management LLC

Location
BOSTON, MA
Portfolio Value
Mid $2,314,454,514
Diversification
Diversified
Filing Date
Global Rank
#831 / 6,901 ▼ 47 · as of Jun 2023
Top Industry
Drug Manufacturers - General 35.6%
3Y Alpha vs SPY
-9.0%
Period ended 3 years ago
Filed Aug 10, 2023 · 2y
14 quarters · since Mar 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+40.1%
SPY
+76.0%
Annualised alpha
-8.8%
Max drawdown
−17.3%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

127 positions · as of Jun 30, 2023 · Δ vs Mar 31, 2023
Top Position
5.9%
+0.2 pts
Top 5
26.0%
+0.4 pts
Top 10
44.5%
+0.4 pts
HHI
273
Sep 2020 → Jun 2023 · range 193 – 280
Diversified−2

Portfolio Trend

14 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2023
Sector % Portfolio Value
Healthcare 98.3% $2,274,023,744
Real Estate 1.7% $40,430,770

Last Quarter's Activity

Export CSV
Jun 30, 2023 vs Mar 31, 2023

Added To

Positions the filer increased
24 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
25 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
6 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
11 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
127 positions · $2,314,454,514 total · as of Jun 30, 2023
Showing 1–50 of 127 positions by value · page 1 of 3
Ticker Company Shares Value (USD) % of Portfolio History